<DOC>
	<DOCNO>NCT01452516</DOCNO>
	<brief_summary>Spine fusion one common procedure perform spinal surgery . Several surgical technique achieve solid union , intertransverse posterolateral fusion ( PLF ) widely use . However , complication develop bone graft material use insufficient achieve desire fusion . With unique property , nanOss Bioactive mixed bone marrow aspirate ( BMA ) graft material obtain new bone growth heal process . It hypothesize use nanOss Bioactive result fusion 12 month , CT evidence bridge trabecular bone , less 3mm translational motion , less 5 degree angular motion . In addition , patient expect see improvement Oswestry Disability Index score , VAS pain score , SF36 score , decrease use pain medication , return work , find satisfaction result surgery .</brief_summary>
	<brief_title>Effectiveness Lumbar Fusion When NanOss Bioactive Is Used With Posterolateral Gutter Fusions</brief_title>
	<detailed_description>The post marketing clinical trial design assess lumbar fusion use interbody cage autograft conjunction instrument posterolateral gutter fusion use nanOss Bioactive bone void filler patient degenerative disc disease ( DDD ) characterize inclusion exclusion criterion list . Patients study recruit 10 clinical site . It estimate 100 patient enrol study . At least 10 investigator participate study . Patients meet inclusion exclusion criterion ask sign inform consent . Preoperatively , patient provide /her medical history complete self assessment form . The investigator perform clinical evaluation . Patients meet criterion entrance study undergo lumbar fusion use interbody cage autograft conjunction instrument posterolateral gutter fusion use nanOss Bioactive combination local autograft bone marrow aspirate ( BMA ) . Anterior lumbar interbody fusion procedure allow . Following surgery , operative discharge information collect . The patient evaluate 6 week , 6 month 12 month postoperatively . At postoperative visit , investigator clinically evaluate patient patient complete self assessment document , Oswestry Disability Index , Quality Life questionnaires surgery satisfaction survey , e.g. , satisfy , satisfy , somewhat unsatisfied , unsatisfied surgery . Fusion status evaluate radiographically visit use plain film . CT scan 12 month evaluate independent radiologist . Complication data record throughout study .</detailed_description>
	<mesh_term>Spondylolisthesis</mesh_term>
	<mesh_term>Spinal Stenosis</mesh_term>
	<mesh_term>Intervertebral Disc Degeneration</mesh_term>
	<criteria>The patient include study follow criterion meet ; 1. least 18 year age skeletally mature 2. must symptomatic spinal stenosis and/or spondylolisthesis degenerative disc disease ( DDD ) one two adjacent level L2S1 require fusion 3. must complete minimum three month unsuccessful conservative , nonoperative care 4. must discogenic back pain without leg pain 5 . DDD must confirm MRI CT scan follow discography ( necessary ) 6. must score least 40 point Oswestry Disability Index 7. must score least 4 10 cm Visual Analog Scale back pain 8. must able comply protocol‟s followup schedule 9. must understand sign inform consent document The patient must exhibit follow criterion ; 1. symptomatic two level 2. previous fusion surgery lumbar level without instrumentation ( prior discectomy , laminotomy , laminectomy nucleolysis operative ( involve ) level &gt; 6 month permit ) 3. 50 % spondylolisthesis 4. lumbar scoliosis great 11 degree 5. osteoporosis* , osteopenia , osteomalacia , Paget‟s disease metabolic bone disease . 6. spinal tumor 7. active arachnoiditis Pioneer Surgical Technology Confidential nanOss Bioactive Post Marketing Clinical Study : March 11 , 2010 Page 8 8. fracture epiphyseal plate fracture stabilization fracture possible . 9 . Impaired calcium metabolism 10. active infection surgical site infection 11. rheumatoid arthritis autoimmune disease 12. chronic steroid use ( used steroid one month within last 6 month ) medical condition require treatment drug know interfere bone heal 13. systemic disease AIDS , HIV , hepatitis ( active ) , tuberculosis 14. morbid obesity define body mass index ( BMI ) &gt; 40 weight 100 lbs ideal body weight 15. smoker unless patient agrees quit least 2 week prior duration study , confirm carboxyhemoglobin test prior surgery 16. psychosocial disorder would preclude accurate evaluation history substance abuse 17. active malignancy except nonmelanoma skin cancer ; history invasive malignancy unless treat remission least five year 18. documented allergy porcine collagen titanium 19. pregnancy , interested become pregnant next four year 20. participation another investigational study within 30 day *Osteoporosis assess time preoperative evaluation base patient‟s history , physical examination review radiographic evaluation . All patient risk osteoporosis must obtain DEXA scan spine hip determine patient severe osteoporosis . The definition patient risk use National Osteoporosis Foundation include following : . Premature menopause ( &lt; 45 year ) ii . Prolonged amenorrhea ( &gt; one year ) iii . Maternal history hip fracture iv . Primary hyperparathyroidism hyperthyroidism v. Chronic renal failure vi . Previous fragility fracture , particularly hip , spine wrist vii . Patients ever take corticosteroid dose &gt; 7.5 mg/day one year . Patients exclude bone mineral density ( BMD ) spine hip 1.0 standard deviation ( SD ) mean normal adult presence one fragility fracture indicate severe osteoporosis . If severe osteoporosis diagnose , patient must exclude investigational study . If patient osteoporosis osteopenia , may include study meet rest inclusion exclusion criterion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>PLF</keyword>
	<keyword>lumbar fusion</keyword>
	<keyword>bone graft</keyword>
	<keyword>biologics</keyword>
</DOC>